Drugs News and Research

RSS

Study sheds light on stem cell technique for treatment of common bleeding disorder

Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients' blood to discover the cause of the disease in individual patients.

6 Apr 2013

Studies, search for genetic risk factors needed to predict individual's risk for traumatic brain injury

One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.

6 Apr 2013

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above.

6 Apr 2013

Study offers new possibilities for developing potent antibacterial drugs

A new study which was performed jointly at Ume- University and the University of Washington in Seattle, USA, discovered that bacteria can degrade the cell membrane of bacterial competitors with enzymes that do not harm their own membrane.

5 Apr 2013

Anirban Maitra to lead pancreatic cancer research at UT MD Anderson Cancer Center

Anirban Maitra, M.B.B.S., a pre-eminent expert in the genetics of pancreatic cancer and the development of targeted therapies for the disease, will lead research at a new center at The University of Texas M.D. Anderson Cancer Center devoted to this highly lethal cancer.

5 Apr 2013

USPTO issues Notice of Allowance on Antares Pharma's patent application for VIBEX QS device

Antares Pharma, Inc. announced that it has received a Notice of Allowance from the U.S. Patent Trade Office on a patent application for the VIBEX QuickShot device, the latest advancement in its proprietary line of VIBEX auto-injector systems.

5 Apr 2013

UEA research could offer long-lasting solution to eating disorders

Researchers at the University of East Anglia have made a discovery in neuroscience that could offer a long-lasting solution to eating disorders such as obesity.

5 Apr 2013

New paper examines some suggested descriptions of mental pain

When we think of pain we generally think of something that is related to our body. But there is a devastating form of pain that is not frequently acknowledged and is a topic of a paper by Eliana Tossani (University of Bologna) in the current issue of Psychotherapy and Psychosomatics.

5 Apr 2013

Non-invasive gut health testing breakthrough

Health and functional claims made for foods such as probiotics still need to prove their effectiveness ― an important part of the answer rests in our small intestines and their role in digestion, and immunity.

5 Apr 2013

Longer looks: Embarrassing accolades; Mapping the brain; Physician pay

Medicine honors its heroes in many ways. But sometimes high accolades can turn out to be highly embarrassing. Consider the annual award for lifetime achievement in preventing and controlling sexual infections, given since 1972 by the American Sexually Transmitted Diseases Association.

5 Apr 2013

UIC College of Pharmacy receives grant to train students in natural product drugs

Elizabeth Martinez hopes to one day discover a cure for menopausal symptoms using an herbal dietary supplement. With the help of a new federal training grant to the University of Illinois at Chicago College of Pharmacy, her vision may become reality.

5 Apr 2013

Roundup: Calif. hospitals to close after homeless care controversy; Texas hospitals spar over indigent care payments

Hospital owner Pacific Health Corp. said it will close its three remaining Southern California hospitals, citing the fallout from a federal fraud case last year in which the company admitted paying to recruit homeless people off skid row in Los Angeles and billing the government for unnecessary care (Terhune, 4/3).

5 Apr 2013

Medicare misperceptions create tougher task for lawmakers

The New York Times reports that public misunderstandings about the specifics of entitlement benefits make trimming Medicare spending more difficult. Meanwhile, Politico reports on an idea that might bridge the partisan divide that plagues these efforts.

5 Apr 2013

Wistar scientists describe mechanics of oncogene-induced senescence

Researchers from The Wistar Institute explain a new molecular mechanism behind the phenomenon of oncogene-induced senescence. By depriving the cell of the ability to make new nucleotides-the building blocks of DNA molecules-cells can suppress cancer development by forcing a damaged cell into a senescent state, where the cell remains alive yet cannot reproduce.

5 Apr 2013

Research findings provide insight into severe bacterial infectious diseases

UT Southwestern Medical Center researchers report that a pathogen annually blamed for an estimated 90 million cases of food-borne illness defeats a host's immune response by using a fat-snipping enzyme to cut off cellular communication.

5 Apr 2013

Researchers identify new set of genetic markers for Alzheimer's

Researchers at Washington University School of Medicine in St. Louis have identified a new set of genetic markers for Alzheimer's that point to a second pathway through which the disease develops.

5 Apr 2013

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

BioInvent International AB announce that the previously communicated positive results from a phase I trial of BI-505 is presented today at The International Myeloma Workshop in Kyoto, Japan.

4 Apr 2013

UC San Francisco researchers outline cell-based therapeutics as a "third pillar” of medicine

Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers.

4 Apr 2013

TSRI scientists identify new drugs for human prion disease

Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.

4 Apr 2013

Overexpression of miR-155 promotes growth of blood vessels in tumors and metastasis

Researchers at Moffitt Cancer Center have determined that the overexpression of microRNA-155 (miR-155), a short, single strand of ribonucleic acid encoded by the miR-155 host gene, promotes the growth of blood vessels in tumors, tumor inflammation, and metastasis.

4 Apr 2013

Drugs News and Research

Study sheds light on stem cell technique for treatment of common bleeding disorder

Studies, search for genetic risk factors needed to predict individual's risk for traumatic brain injury

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Study offers new possibilities for developing potent antibacterial drugs

Anirban Maitra to lead pancreatic cancer research at UT MD Anderson Cancer Center

USPTO issues Notice of Allowance on Antares Pharma's patent application for VIBEX QS device

UEA research could offer long-lasting solution to eating disorders

New paper examines some suggested descriptions of mental pain

Non-invasive gut health testing breakthrough

Longer looks: Embarrassing accolades; Mapping the brain; Physician pay

UIC College of Pharmacy receives grant to train students in natural product drugs

Roundup: Calif. hospitals to close after homeless care controversy; Texas hospitals spar over indigent care payments

Medicare misperceptions create tougher task for lawmakers

Wistar scientists describe mechanics of oncogene-induced senescence

Research findings provide insight into severe bacterial infectious diseases

Researchers identify new set of genetic markers for Alzheimer's

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

UC San Francisco researchers outline cell-based therapeutics as a "third pillar” of medicine

TSRI scientists identify new drugs for human prion disease

Overexpression of miR-155 promotes growth of blood vessels in tumors and metastasis

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News